These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22841133)

  • 1. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E; Hanauer SB
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
    Laish I; Pomeranz I; Kitay-Cohen Y; Konikof F
    Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.
    Pola S; Boland BS; Lin GY; Kuo A; Sandborn WJ
    Dig Dis Sci; 2014 Jul; 59(7):1642-4. PubMed ID: 24535249
    [No Abstract]   [Full Text] [Related]  

  • 7. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
    Arnott ID; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.
    Andersen JM; Tiede JJ
    Pharmacotherapy; 1997; 17(1):173-6. PubMed ID: 9017780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L; Marko C; Breidert M
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
    Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiopurines in Crohn's disease, is there something new?
    Miheller P; Lakatos PL
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.
    Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB
    Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D; Decaestecker J; De Wulf D; Ghillebert G; Van Vlierberghe H; Van Dorpe J; Baert F
    Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease.
    Ananthakrishnan AN; Attila T; Otterson MF; Lipchik RJ; Massey BT; Komorowski RA; Binion DG
    J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden onset of Multiple nevi after administration of 6-mercaptopurine in an adult with Crohn's disease: a case report.
    Kakrida M; Orengo I; Markus R
    Int J Dermatol; 2005 Apr; 44(4):334-6. PubMed ID: 15811090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.